Porton Pharma Solutions: Announcement on the launch of foreign exchange derivatives trading business for hedging purposes in 2024
Apr 26 12:00 ET
Porton Pharma Solutions: 2023 Internal Control Self-Assessment Report
Apr 26 12:00 ET
Porton Pharma Solutions: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Apr 26 12:00 ET
Porton Pharma Solutions: Announcement on preparation for impairment of assets accrued in 2023 and scrapping of some assets
Apr 26 12:00 ET
Porton Pharma Solutions: Notice on convening the 2023 Annual General Meeting of Shareholders
Apr 26 12:00 ET
Porton Pharma Solutions: Amendments to the Articles of Association
Apr 26 12:00 ET
Porton Pharma Solutions: Foreign Investment Management System (April 2024)
Apr 26 12:00 ET
Porton Pharma Solutions: 2023 Financial Results Report
Apr 26 12:00 ET
Boteng Co., Ltd.: Announcement on the completion of the registration of industrial and commercial changes by the holding subsidiary
Apr 3 05:42 ET
Boteng Shares: Announcement on the 2023 Employee Stock Ownership Plan to Complete Stock Purchase
Feb 27 02:40 ET
Boteng Co., Ltd.: Announcement on participating in the subscription of investment fund shares
Feb 23 04:40 ET
Boteng Co., Ltd.: Announcement on the wholly-owned subsidiary being re-certified as a high-tech enterprise
Feb 1 05:00 ET
Boteng Co., Ltd.: Announcement on completing the registration of industrial and commercial changes
Dec 29, 2023 03:10 ET
Boteng Co., Ltd.: Announcement on profit distribution for wholly-owned subsidiaries
Dec 29, 2023 03:09 ET
Boteng Co., Ltd.: Announcement on the resignation of the company\'s senior management
Dec 3, 2023 11:00 ET
Boteng Co., Ltd.: Legal Opinion of Beijing Wanshang Tianqin Law Firm on the 5th Extraordinary General Meeting of Shareholders of Chongqing Boteng Pharmaceutical Technology Co., Ltd. in 2023
Nov 27, 2023 06:06 ET
Boteng Co., Ltd.: Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2023
Nov 27, 2023 06:06 ET
Boteng Co., Ltd.: Announcement on Wholly-owned Subsidiaries Passing U.S. FDA On-Site Inspection
Nov 20, 2023 05:00 ET
Boteng Co., Ltd.: Board Remuneration and Assessment Committee Rules of Procedure (November 2023)
Nov 10, 2023 11:00 ET
Boteng Co., Ltd.: Amendments to the Articles of Association
Nov 10, 2023 11:00 ET
No Data
No Data